Neurodome

Neurodome, Inc., an innovative technology company based in Xi'an, focuses on the research and development of neuromodulation products for neural function regulation. Its first neuromodulation product for Parkinson's disease began clinical preliminary trials in 2021. After years of accumulation, Neurodome has obtained dozens of patents related to technologies in the neuromodulation field. In terms of product development, since 2018, the Neurodome team has rapidly completed the iterative development of four generations of TI products. The performance of these products has been fully optimized in terms of depth, stability, and coverage range.